Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$10,733,282
+$466,650 QoQ
Shares Held
68,487
+1.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#168
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Baird Financial Group, Inc. holds $2,528,024,463 across 14 Drug Manufacturers - General names. NVS ranks #10 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,799,159 | $1,218,842,409 | |
| 2 | ABBV |
AbbVie Inc.
|
2,042,445 | $513,960,857 | |
| 3 | LLY |
ELI LILLY & Co
|
303,814 | $364,403,654 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,064,683 | $136,811,765 | |
| 5 | AMGN |
Amgen Inc
|
339,825 | $123,057,427 | |
| 6 | PFE |
Pfizer Inc
|
2,312,826 | $55,692,848 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
292,295 | $36,928,549 | |
| 8 | AZN |
Astrazeneca PLC
|
134,149 | $25,437,332 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,733,282 | 68,487 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $10,266,632 | 67,212 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $9,428,239 | 68,385 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $8,911,653 | 69,492 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $8,357,191 | 69,062 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $9,490,403 | 85,131 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $8,232,036 | 84,596 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $10,323,159 | 89,751 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $9,292,253 | 87,284 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,897,036 | 81,640 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $7,638,783 | 75,654 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $7,477,337 | 73,408 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,753,318 | 76,834 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,590,788 | 71,639 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,617,115 | 72,940 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,781,458 | 89,218 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $8,039,731 | 95,111 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $8,378,106 | 95,477 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $7,990,821 | 91,355 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $7,486,468 | 91,544 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $8,229,939 | 90,201 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $7,696,533 | 90,039 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $8,310,689 | 88,009 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $7,292,204 | 83,857 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $7,203,715 | 82,479 | Shares | Defined | 2020-10-22 | |
| 2020-03-31 | $7,550,028 | 91,571 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||